To foster the continued success of the biomanufacturing industry, North Carolina State University has joined forces with a French university to provide biomanufacturing training, education, and process services in the United States and Europe.
Researchers at Oregon State University have, for the first time, traced the actions of a known carcinogen in cooked meat to its complex biological effects on microRNA and cancer stem cells. The scientists also found that consumption of spinach can partially offset the damaging effects of the carcinogen.
A new approach to drug design, pioneered by a group of researchers at the University of California, San Francisco and Mt. Sinai, New York, promises to help identify future drugs to fight cancer and other diseases that will be more effective and have fewer side effects.
As science rushes to develop safe weight loss drugs, a new research report suggests a different angle: What if there were a pill that would make you want to exercise harder? It may sound strange, but recent work with hormones and mice suggests that it might be possible.
A new set of computer models has successfully predicted negative side effects in hundreds of current drugs, based on the similarity between their chemical structures and those molecules known to cause side effects, according to a paper.
At a recent weekend conference of more than 30,000 specialists, experts reported seeing a major escalation in the arms race against cancer. Several new advances, including “smart” drugs, immune system aids, and treatments based on genetic pathways, offer new hope for battling previously intractable diseases.
University of California, Los Angeles biochemists have designed specialized proteins that assemble themselves to form tiny molecular cages hundreds of times smaller than a single cell. The creation of these miniature structures may be the first step toward developing new methods of drug delivery or even designing artificial vaccines.
Computer chips of a type more commonly found in games consoles have been used by scientists at the University of Bristol to reveal how the flu virus resists antiflu drugs such as Relenza and Tamiflu.
For 50 years scientists have been unsure how the bacteria that gives humans cholera manages to resist one of our basic innate immune responses. That mystery has now been solved, thanks to research from biologists at The University of Texas at Austin. The answers may help clear the way for a new class of antibiotics that don't directly shut down pathogenic bacteria, but instead disable their defenses so that our own immune systems can do the killing.
A seaweed considered a threat to the healthy growth of coral reefs in Hawaii may possess the ability to produce substances that could one day treat human diseases, a new study led by scientists at Scripps Institution of Oceanography at University of California, San Diego has revealed.
The highly pathogenic hantavirus causes a condition known as hantavirus pulmonary syndrome (HPS), which has a case fatality rate of 35-40%. To help the fight against a disease that has no vaccine, U.S. Army scientists and industry collaborators have successfully protected laboratory animals from lethal hantavirus disease using a novel approach that combines DNA vaccines and duck eggs.
Hundreds of tiny hollow needles stick out of the membrane of a bacteria that causes cholera. These are treacherous tools that makes bacterial pathogens so dangerous. Researchers in the U.S. and Germany have now seen this structure in 3D detail at atomic resolution. The images may help drug researchers.
The U.S. Food and Drug Administration (FDA) generally approves drug therapies faster and earlier than its counterparts in Canada and Europe, according to a new study by Yale University School of Medicine researchers. The study counters perceptions that the drug approval process in the U.S. is especially slow.
Advisers to government health regulators late Thursday recommended that they approve sales of what would be the first new prescription weight-loss drug in the U.S. in more than a decade, despite concerns over cardiac risks.
Doctors have long known that treating patients with multiple cancer drugs often produces better results than treatment with just a single drug. Now, a study from Massachusetts Institute of Technology shows that the order and timing of drug administration can have a dramatic effect.
The superbugs have met their match. Conceived at Nanyang Technological University, it comes in the form of a coating which has a magnetic-like feature that attracts bacteria and kills them without the need for antibiotics.
Researchers at the University of Michigan have identified new targets for drugs that could potentially treat anthrax, the deadly infection caused by Bacillus anthracis . The team found a new way to block the bacteria's ability to capture iron, which is vital to its survival and its disease-causing properties.
A pill that has long been used to treat HIV has moved one step closer to becoming the first drug approved to prevent healthy people from becoming infected with the virus that causes AIDS. The Food and Drug Administration said Tuesday that Gilead Sciences' Truvada appears to be safe and effective for HIV prevention.
A cross-disciplinary team of researchers at the University of Maryland has designed a molecular container that can hold drug molecules and increase their solubility, in one case up to nearly 3000 times. Their discovery opens the possibility of rehabilitating drug candidates that were insufficiently soluble.
University of Manchester scientists have discovered an Achilles heel within cells that bacteria are able to exploit to cause and spread infection. The researchers say their findings could lead to the development of new anti-infective drugs as alternatives to antibiotics whose overuse has led to resistance.
Penicillin and other antibiotics have revolutionized medicine, turning once-deadly diseases into easily treatable ailments. However, while antibiotics have been in use for more than 70 years, the exact mechanism by which they kill bacteria has remained a mystery. Now a new study reveals the killing mechanism behind all three major classes of antibiotics.
Antibiotics are mixed with animal feed to help livestock, pigs and chickens put on weight and stay healthy in crowded barns. Scientists have warned that this routine use leads to the growth of antibiotic-resistant germs that can be passed to humans. Now the Food and Drug Administration is weighing in on the matter, calling on drug companies to help limit the use antibiotics.
Combining two strategies that are designed to improve the results of cancer treatment—angiogenesis inhibitors and nanomedicines—may only be successful if the smallest nanomedicines are used. A new study by researchers at Harvard University and Massachusetts General Hospital has found that normalizing blood vessels within tumors can actually block the delivery of larger nanotherapy molecules.
Plants that contain the ingredients for the popular licorice treat employ a complex assembly line of enzymes to produce the glycyrrhizin molecule, a potent sweetener that is also an effective anti-inflammatory and antiviral agent. A newly discovered enzyme brings scientists one step closer to understanding how plants like licorice root manufacture a molecule with potent medicinal properties.
An international consortium has determined the structure of an important new drug target in complex with a synthetic molecule designed by University of Bath researchers, opening up new avenues for drug discovery.